Harding Loevner’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
CIP
Harding Loevner's RGEN Position: Q1 2025 in Review
Harding Loevner sold out of Repligen (RGEN) in Q1 2025, closing a stake of 340,083 shares — an estimated $49M sold.
Harding Loevner first reported a position in RGEN in Q3 2019 and held it in 19 quarters. The position peaked at $136M in Q3 2024. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2025.
- Harding Loevner reported no remaining Repligen position as of Q1 2025 after selling out during the quarter.
- Harding Loevner sold 340,083 Repligen shares in Q1 2025, an estimated $49M.
- Harding Loevner first reported a position in Repligen in Q3 2019 and held it in 19 quarters.
- Harding Loevner's Repligen position peaked at $136M in Q3 2024.
- 442 funds tracked by Wall St. Rank held Repligen as of Q1 2025.
Based on Harding Loevner's 13F filing for Q1 2025, filed 15 May 2025.